初次全髋关节置换术植入物选择是否影响患者报告结局
该研究基于单医疗系统内4716例初次全髋关节置换术患者的前瞻性数据,分析股骨与髋臼假体类型及摩擦界面是否影响术后1年患者报告疼痛、功能和活动度的改善。结果显示多数植入物参数与未达最小临床重要差异、患者可接受症状状态或实质性临床获益无关,仅36mm股骨头相比28mm股骨头与UCLA活动评分改善不足的 odds 更低相关。
要点
- 多数植入物参数不影响HOOS疼痛、功能及UCLA活动评分达MCID的比例。
- 36mm股骨头较28mm股骨头与UCLA活动评分改善不足 odds 更低相关(OR 0.64)。
- 植入物相关标准不是达到PASS或SCB的显著驱动因素。
核心结论
- 总体而言,全髋关节置换术植入物特征不是疼痛和功能改善不足的驱动因素。
- 外科医生应使用具有可接受追踪记录、能实现稳定固定并恢复髋关节生物力学的植入物。
研究设计与样本
- 前瞻性收集2015年7月至2018年8月单医疗系统内4716例初次全髋关节置换术患者数据,采用标准化诊疗路径。
- 按股骨和髋臼假体类型及摩擦界面分类,分析术后1年患者报告结局指标及HOOS和UCLA活动评分改善情况。
主要发现
- 3519例(74.6%)患者有术后1年PROM数据。
- 所有分析植入物参数在HOOS疼痛、HOOS PS或UCLA活动评分达MCID的比例上无差异。
- 多变量回归显示植入物选择不是HOOS疼痛和HOOS PS改善不足的显著驱动因素(p > 0.05)。
- 36mm股骨头较28mm股骨头与UCLA活动评分改善不足 odds 更低相关(OR 0.64;95%CI 0.47-0.86;p = 0.003)。
- 植入物相关标准不是达到PASS或HOOS疼痛SCB的显著驱动因素。
关键数值与推荐
- 改善不足定义为PROMs变化小于HOOS疼痛和身体功能简表(PS)的MCID,以及UCLA活动评分未改善至超过主要居家活动状态(评分≤3)。
- MCID和SCB阈值采用文献报道值。
临床怎么用
- 选择具有可接受追踪记录、能实现稳定固定并恢复髋关节生物力学的植入物。
- 植入物选择对多数患者报告结局影响有限,无需过度纠结特定假体参数。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Total hip arthroplasty (THA) is a reliable operation, but it is critical that orthopaedic surgeons characterize which surgical factors influence patient-reported outcomes. The purpose of this study was to determine whether implant selection at the time of THA affects the odds of having (1) inadequate improvement according to patient-reported pain, function, and activity; (2) failure to achieve a substantial clinical benefit (SCB) with respect to pain; or (3) failure to achieve a patient-acceptable symptomatic state (PASS) according to pain and function. METHODS: Prospective data were collected from 4,716 patients who underwent primary THA (from July 2015 to August 2018) in a single health-care system with standardized care pathways. Patients were categorized according to the type of femoral and acetabular components and bearing surface used. Outcomes included 1-year postoperative patient-reported outcome measures (PROMs) and improvement in the Hip disability and Osteoarthritis Outcome Score (HOOS) and the University of California at Los Angeles (UCLA) activity score. Inadequate improvement was defined as PROMs that changed by less than the minimal clinically important difference (MCID) for the HOOS pain and physical function short form (PS) and as failure to improve beyond a mostly homebound activity status for the UCLA activity score (a score of ≤3). The MCID and SCB thresholds were set at values reported in the literature. RESULTS: One-year PROM data were available for 3,519 patients (74.6%). There were no differences in the proportion of patients who attained the MCID in terms of HOOS pain, HOOS PS, or UCLA activity scores at 1 year for all analyzed implant parameters. Multivariate regression demonstrated that implant selection was not a significant driver of inadequate improvement, according to HOOS pain and HOOS PS (p > 0.05). Larger (36-mm) femoral heads demonstrated lower odds of inadequate improvement versus 28-mm femoral heads according to UCLA activity scores (odds ratio [OR]: 0.64; 95% confidence interval, 0.47 to 0.86; p = 0.003). Implant-related criteria were not significant drivers of attaining a PASS or achieving an SCB with respect to HOOS pain. CONCLUSIONS: For the most part, THA implant characteristics are not drivers of inadequate improvement with respect to pain and function. Surgeons should utilize implants with an acceptable track record that allow stable fixation and restoration of hip biomechanics. LEVEL OF EVIDENCE: Therapeutic Level III. See Instructions for Authors for a complete description of levels of evidence.
引用
- Campbell A, Emara AK, Klika A, et al. Does Implant Selection Affect Patient-Reported Outcome Measures After Primary Total Hip Arthroplasty? J Bone Joint Surg Am. 2021. PMID: 34495897. doi:10.2106/JBJS.20.01931
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。